An Exploration of Key Issues in IBD: A CME/CE-Certified Microlearning Series

Download All
Learn about the latest guideline-recommended therapies for initial induction treatment of moderate to severe UC and CD
Bruce E. Sands, MD, MS

Early Induction Therapy for IBD

In this concise video, review a synthesis of recommendations from AGA and ACG guidelines on the treatment of moderate to severe UC and CD, and hear expert discussion on the rationale for early induction therapy with a biologic.

Bruce E. Sands, MD, MS Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: April 26, 2021 Expired: April 25, 2022

Learn about current guideline recommendations for the treatment of moderate to severe UC and CD, including the rationale for combination therapy.

Bruce E. Sands, MD, MS Released: April 26, 2021

With advances in novel biologic and small molecule treatment options, new diagnostics, and increasingly complex treatment algorithms, STRIDE-II extends on the previous STRIDE recommendations to help define reasonable treatment targets for IBD.

Bruce E. Sands, MD, MS Released: May 5, 2021
Provided by Clinical Care Options

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Bristol-Myers Squibb

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue